Literature DB >> 26058076

CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia.

Diana Passaro1, Marta Irigoyen2, Claire Catherinet2, Stéphanie Gachet2, Cindy Da Costa De Jesus2, Charlène Lasgi2, Christine Tran Quang2, Jacques Ghysdael3.   

Abstract

Impaired cell migration has been demonstrated in T cell acute lymphoblastic leukemia (T-ALL) cells upon calcineurin inactivation, among other phenotypic traits including increased apoptosis, inhibition of cell proliferation, and ultimately inhibition of leukemia-initiating cell (LIC) activity. Herein we demonstrate that the chemokine receptor CXCR4 is essential to the LIC activity of T-ALL leukemic cells both in NOTCH-induced mouse T-ALL and human T-ALL xenograft models. We further demonstrate that calcineurin regulates CXCR4 cell-surface expression in a cortactin-dependent manner, a mechanism essential to the migratory properties of T-ALL cells. Because 20%-25% of pediatric and over 50% of adult patients with T-ALL do not achieve complete remission and relapse, our results call for clinical trials incorporating CXCR4 antagonists in T-ALL treatment.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26058076     DOI: 10.1016/j.ccell.2015.05.003

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  73 in total

1.  A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10-03).

Authors:  Todd M Cooper; Edward Allan Racela Sison; Sharyn D Baker; Lie Li; Amina Ahmed; Tanya Trippett; Lia Gore; Margaret E Macy; Aru Narendran; Keith August; Michael J Absalon; Jessica Boklan; Jessica Pollard; Daniel Magoon; Patrick A Brown
Journal:  Pediatr Blood Cancer       Date:  2017-04-14       Impact factor: 3.167

Review 2.  Relapsed T Cell ALL: Current Approaches and New Directions.

Authors:  Christine M McMahon; Selina M Luger
Journal:  Curr Hematol Malig Rep       Date:  2019-04       Impact factor: 3.952

3.  Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cells.

Authors:  Darja Karpova; Julie K Ritchey; Matthew S Holt; Grazia Abou-Ezzi; Darlene Monlish; Lena Batoon; Susan Millard; Gabriele Spohn; Eliza Wiercinska; Ezhil Chendamarai; Wei Yang; Stephanie Christ; Leah Gehrs; Laura G Schuettpelz; Klaus Dembowsky; Allison R Pettit; Michael P Rettig; Halvard Bonig; John F DiPersio
Journal:  Blood       Date:  2017-04-11       Impact factor: 22.113

4.  The calcineurin protein phosphatase is dispensable for BCR-ABL-induced B-ALL maintenance, propagation and response to dasatinib.

Authors:  F Rocchetti; C Tran Quang; A L Maragno; J Nguyen; C Lasgi; J Ghysdael
Journal:  Leukemia       Date:  2016-10-03       Impact factor: 11.528

Review 5.  Immune-Based Therapies in Acute Leukemia.

Authors:  Matthew T Witkowski; Audrey Lasry; William L Carroll; Iannis Aifantis
Journal:  Trends Cancer       Date:  2019-08-29

Review 6.  The genetics and mechanisms of T cell acute lymphoblastic leukaemia.

Authors:  Laura Belver; Adolfo Ferrando
Journal:  Nat Rev Cancer       Date:  2016-07-25       Impact factor: 60.716

Review 7.  Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia.

Authors:  Sonali P Barwe; Anthony Quagliano; Anilkumar Gopalakrishnapillai
Journal:  Semin Oncol       Date:  2017-07-11       Impact factor: 4.929

8.  Bone marrow sites differently imprint dormancy and chemoresistance to T-cell acute lymphoblastic leukemia.

Authors:  Xavier Cahu; Julien Calvo; Sandrine Poglio; Nais Prade; Benoit Colsch; Marie-Laure Arcangeli; Thierry Leblanc; Arnaud Petit; Frederic Baleydier; Andre Baruchel; Judith Landman-Parker; Christophe Junot; Jerome Larghero; Paola Ballerini; Eric Delabesse; Benjamin Uzan; Francoise Pflumio
Journal:  Blood Adv       Date:  2017-09-08

9.  Leukemia-derived exosomes and cytokines pave the way for entry into the brain.

Authors:  Ichiko Kinjyo; Denis Bragin; Rachel Grattan; Stuart S Winter; Bridget S Wilson
Journal:  J Leukoc Biol       Date:  2019-01-31       Impact factor: 4.962

10.  Ribosomal Protein Rpl22 Controls the Dissemination of T-cell Lymphoma.

Authors:  Shuyun Rao; Kathy Q Cai; Jason E Stadanlick; Noa Greenberg-Kushnir; Nehal Solanki-Patel; Sang-Yun Lee; Shawn P Fahl; Joseph R Testa; David L Wiest
Journal:  Cancer Res       Date:  2016-04-05       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.